CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-30 | Kaseta Michael Director | Grant or award | +53,960 | 53,960 | ||
| 2026-01-30 | Duarte Ira EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +216,562 | 216,562 | ||
| 2026-01-30 | Duarte Ira EVP, Chief Financial Officer | Grant or award · Performance Stock Units | +216,561 | 216,561 | ||
| 2026-01-30 | Johnson Craig A Director | Grant or award | +53,960 | 53,960 | ||
| 2026-01-30 | Cusack Thomas Director | Grant or award | +53,960 | 53,960 | ||
| 2026-01-30 | Forbes William P EVP, Chief Development Officer | Grant or award · Restricted Stock Units | +188,315 | 188,315 | ||
| 2026-01-30 | Forbes William P EVP, Chief Development Officer | Grant or award · Performance Stock Units | +188,314 | 188,314 | ||
| 2026-01-30 | Dissanaike Sharmila Director | Grant or award | +53,960 | 53,960 | ||
| 2026-01-30 | Hensley Mark Earl Chief Operating Officer | Grant or award · Restricted Stock Units | +188,315 | 188,315 | ||
| 2026-01-30 | Hensley Mark Earl Chief Operating Officer | Grant or award · Performance Stock Units | +188,314 | 188,314 | ||
| 2026-01-30 | Morgan Adam Director | Grant or award | +53,960 | 123,737 | ||
| 2026-01-19 | Forbes William P EVP, Chief Development Officer | Option exercise | +3,875 | 170,078 | ||
| 2026-01-19 | Forbes William P EVP, Chief Development Officer | Option exercise · Restricted Stock Units | −3,875 | 30,994 | ||
| 2026-01-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +3,875 | 183,661 | ||
| 2026-01-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −3,875 | 30,994 | ||
| 2026-01-19 | Collard Craig A Chief Executive Officer | Option exercise | +13,797 | 536,921 | ||
| 2026-01-19 | Collard Craig A Chief Executive Officer | Option exercise · Restricted Stock Units | −13,797 | 110,375 | ||
| 2025-11-08 | Cusack Thomas Director | Grant or award | +37,879 | 37,879 | ||
| 2025-11-08 | Cusack Thomas Director | Grant or award · Stock Option (Right to Buy) | +227,272 | $1.10 | $250K | 227,272 |
| 2025-10-31 | Forbes William P EVP, Chief Development Officer | Option exercise | +11,694 | 166,203 |
Page 6 of 28 · 557 trades